ReviewCancer imaging : the official publication of the International Cancer Imaging Society2006
Imaging of metastatic melanoma.
Review in Cancer imaging : the official publication of the International Cancer Imaging Society, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 46 citations in OpenAlex.
- T2 hypointense lesions of the abdomen: imaging spectrum and diagnostic considerations.Abdominal radiology (New York) · 2026Review
- Modality-level attribution and redundancy-aware radiomics for MRI-based differentiation of melanoma and NSCLC brain metastases.Frontiers in oncology · 2026Article
- Quantum dot: a next-generation tool for cancer diagnosis at an early stage.Journal of the Egyptian National Cancer Institute · 2025Review
- CT, MRI and PET/CT features of abdominal manifestations of cutaneous melanoma: a review of current concepts in the era of tumor-specific therapies.Abdominal radiology (New York) · 2021Review
- CT diagnosis of ilioinguinal lymph node metastases in melanoma using radiological characteristics beyond size and asymmetry.BJS open · 2021Article
- Disorders of neural crest derivates in oncoradiological practice.Translational cancer research · 2019Review
- Gallbladder and small bowel metastasis of regressive melanoma: a case report.BJR case reports · 2019Article
- Metastatic melanoma to the testis.BJR case reports · 2018Article
- Magnetic resonance imaging appearance of soft-tissue metastases: our experience at an orthopedic oncology center.Skeletal radiology · 2017Article
- Clickable, hydrophilic ligand for fac-[M(I)(CO)3](+) (M = Re/(99m)Tc) applied in an S-functionalized α-MSH peptide.Bioconjugate chemistry · 2014Article
- Novel, cysteine-modified chelation strategy for the incorporation of [M(I)(CO)(3)](+) (M = Re, (99m)Tc) in an α-MSH peptide.Bioconjugate chemistry · 2012Article
- Incidental pelvic lesions in the oncology patient.Cancer imaging : the official publication of the International Cancer Imaging Society · 2011Review
- Anatomical and molecular imaging of skin cancer.Clinical, cosmetic and investigational dermatology · 2008Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cutaneous cancer is now the most common human malignancy and in the UK malignant melanoma comprises 11% of all skin cancers. Eighty percent of malignant melanoma is thought to be related to excessive exposure to sunlight, particularly in childhood. Although the least common skin cancer, malignant melanoma is the most deadly. In 1999 it killed over 1600 individuals in the UK and by 2004, in the USA, 55,100 new cases were anticipated. The incidence of this disease is increasing more rapidly than any other malignancy and in males there was a four-fold increase in incidence between 1971 and 1997 whilst there was a three-fold increase in women. Cutaneous melanoma is arguably the most widely metastasising neoplastic disease and it has a particularly unpredictable pattern of spread. Imaging has an important role in the management of this disease as the demonstration and delineation of metastases influences management and prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.